Princeton, New Jersey
United States
31
2024-04-18
17
2023-07-18
These are the the leading inventors for applications assigned to Advaxis, Inc.:
Advaxis, Inc. based in Princeton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF
#2 | 2023-11-09LISTERIA-BASED COMPOSITIONS COMPRISING A PEPTIDE MINIGENE EXPRESSION SYSTEM AND METHODS OF USE THEREOF
#3 | 2021-08-12 ✅ Patent 11,702,664 granted on 2023-07-18Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#4 | 2021-08-05COMPOSITIONS AND METHODS FOR EVALUATING POTENCY OF LISTERIA-BASED IMMUNOTHERAPEUTICS
#5 | 2021-06-17IMMUNOGENIC HETEROCLITIC PEPTIDES FROM CANCER-ASSOCIATED PROTEINS AND METHODS OF USE THEREOF
#6 | 2021-01-07COMPOSITIONS AND METHODS FOR EVALUATING ATTENUATION AND INFECTIVITY OF LISTERIA STRAINS
#7 | 2020-08-20 ✅ Patent 11,179,339 granted on 2021-11-23Compositions and methods for lyophilization of bacteria or listeria strains
#8 | 2020-03-05 ✅ Patent 11,446,369 granted on 2022-09-20Compositions and methods comprising KLK3 or FOLH1 antigen
#9 | 2020-02-27COMBINATION OF LISTERIA-BASED VACCINE WITH ANTI-CTLA-4 OR ANTI-CD137 ANTIBODIES
#10 | 2019-12-19PERSONALIZED DELIVERY VECTOR-BASED IMMUNOTHERAPY AND USES THEREOF
#11 | 2019-10-24 ✅ Patent 11,897,927 granted on 2024-02-13Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
#12 | 2019-08-15Listeria-Based Immunogenic Compositions Comprising Wilms Tumor Protein Antigens And Methods Of Use Thereof
#13 | 2019-08-08RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF PRODUCING THE SAME
#14 | 2019-01-31Personalized Delivery Vector-Based Immunotherapy and Uses Thereof
#15 | 2019-01-03 ✅ Patent 10,900,044 granted on 2021-01-26Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#16 | 2018-10-25Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment
#17 | 2017-04-20 ✅ Patent 10,143,734 granted on 2018-12-04Biomarker directed multi-target immunotherapy
#18 | 2017-04-13COMPOSITIONS AND METHODS COMPRISING KLK3 OR FOLH1 ANTIGEN
#19 | 2017-02-16 ✅ Patent 10,258,679 granted on 2019-04-16Recombinant vaccine strains and methods of producing the same
#20 | 2016-11-10 ✅ Patent 10,064,898 granted on 2018-09-04Listeria-based adjuvants
#21 | 2016-08-04METHODS OF USING RECOMBINANT LISTERIA VACCINE STRAINS IN DISEASE IMMUNOTHERAPY
#22 | 2016-01-28 ✅ Patent 9,907,849 granted on 2018-03-06Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer
#23 | 2015-11-26 ✅ Patent 9,549,973 granted on 2017-01-24Compositions and methods comprising KLK3 or FOLH1 antigen
#24 | 2015-04-09 ✅ Patent 10,058,599 granted on 2018-08-28Suppressor cell function inhibition following vaccine treatment
#25 | 2014-09-04 ✅ Patent 9,499,602 granted on 2016-11-22Non-hemolytic LLO fusion proteins and methods of utilizing same
#26 | 2014-08-21COMPOSITIONS AND METHODS FOR PREVENTION OF ESCAPE MUTATION IN THE TREATMENT OF HER2/NEU OVER-EXPRESSING TUMORS
#27 | 2014-07-17 ✅ Patent 9,463,227 granted on 2016-10-11Listeria-based adjuvants
#28 | 2012-07-12 ✅ Patent 8,956,621 granted on 2015-02-17Compositions and methods for treatment of cervical dysplasia
#29 | 2012-01-19 ✅ Patent 9,017,660 granted on 2015-04-28Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
#30 | 2011-06-16 ✅ Patent 9,084,747 granted on 2015-07-21Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors
#31 | 2007-11-01 ✅ Patent 9,012,141 granted on 2015-04-21Compositions and methods comprising KLK3 of FOLH1 antigen
Also check out ADVAXIS, INC.'s (Princeton, United States) applicant profile with 15 patent applications submitted.
75445 ⎘